Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

GGenerate Biomedicines, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
G

Generate Biomedicines, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 1, 2026ARNOLD FRANCESDirector1,000Common Stock—Sell
Mar 4, 2026Nally MichaelChief Executive Officer20,000Common Stock—Buy
Mar 2, 2026AFEYAN NOUBARDirector, 10% Owner11,814,340Series C Preferred Stock—Conversion
Mar 2, 2026AFEYAN NOUBARDirector, 10% Owner14,345,986Series B Preferred Stock—Conversion
Mar 2, 2026AFEYAN NOUBARDirector, 10% Owner74,000,000Series A Preferred Stock—Conversion
Mar 2, 2026AFEYAN NOUBARDirector, 10% Owner3,125,000Common Stock—Buy
Mar 2, 2026AFEYAN NOUBARDirector, 10% Owner60,382,814Common Stock—Conversion
Mar 2, 2026Mendillo Jane LDirector1,500Common Stock—Buy
Mar 2, 2026Bancel StephaneDirector724,160Common Stock—Conversion
Mar 2, 2026Nally MichaelChief Executive Officer658,327Common Stock—Conversion
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions